The present invention relates to immunoglobulins that bind IgE and FcγRIIb with high affinity, said compositions comprising said immunoglobulins being capable of inhibiting cells that express membrane-anchored IgE. Such compositions are useful for treating IgE-mediated disorders, including allergies and asthma.